Optimizing whole brain radiation therapy dose and fractionation: Results from a prospective phase III trial
In patients receiving whole brain radiotherapy after surgical resection of brain metastasis, this article addresses the optimal radiotherapy dose for both tumor control and minimization of short and long-term toxicities.
Category
  • Central Nervous System
  • Palliative Care
Format
  • Journal SA-CME
Credits
  • SA-CME
  • Certificate of Attendance
Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an ASTRO Clinical Practice Guideline
The present CME journal activity provides practitioners with the knowledge about recent developments in clinical literature of radiotherapy for skin cancers.
Category
  • Sarcoma/Cutaneous
Format
  • Journal SA-CME
Credits
  • SA-CME
  • Certificate of Attendance
Minimum Data Elements for Radiation Oncology: An ASTRO Consensus Paper
PRO Journal for November-December (Volume 105, Issue 6) provides practitioners with the knowledge about minimum data elements for standardization of radiation oncology data.
Category
  • Other
Format
  • Journal SA-CME
Credits
  • SA-CME
  • Certificate of Attendance
Safety and Efficacy of liver stereotactic body radiation therapy for hepatocellular carcinoma following segmental transarterial radioembolization
IJROBP Journal SA-CME activity for December 1, 2019 (Volume 105, Issue 5) addresses the safety of liver SBRT after transarterial redioembolization.
Category
  • Gastrointestinal Cancer
Format
  • Journal SA-CME
Credits
  • SA-CME
  • Certificate of Attendance
Dose Gradient Index for Stereotactic Radiosurgery/Radiotherapy
The dose gradient index (DGI) was developed as a quantitative metric for characterizing radiation dose fall-off with respect to distance away from the outer surface of a target volume [1].
Category
  • Central Nervous System
  • Physics
Format
  • Journal SA-CME
Credits
  • SA-CME
  • Certificate of Attendance
Radiation dose escalation or longer androgen suppression to prevent distant progression in men with locally advanced prostate cancer?
This journal activity provides practitioners with prospective data supporting the use of longer term ADT in men with high-risk prostate cancer even if they are receiving high dose EBRT of HDR brachytherapy.
Category
  • Genitourinary Cancer
Format
  • Journal SA-CME
Credits
  • SA-CME
  • Certificate of Attendance
Quantification of Esophageal Tumor Motion and Investigation of Different Image-Guided Correction Strategies
This journal activity provides practitioners with the knowledge about motion when treating esophageal cancer with radiotherapy.
Category
  • Gastrointestinal Cancer
Format
  • Journal SA-CME
Credits
  • SA-CME
  • Certificate of Attendance
Predicting Survival for Patients with Metastatic Disease
IJROBP Journal SA-CME activity for January 1, 2020 (Volume 106, Issue 1) allows practitioners to integrate new biology into their thinking about the management of localized breast cancer. 
Category
  • Breast Cancer
Format
  • Journal SA-CME
Credits
  • SA-CME
  • Certificate of Attendance
Derivation of dose/volume constraints for the anorectum from clinician and patient-reported outcomes in the CHHiP trial of radiotherapy fractionation
IJROBP Journal SA-CME activity for April 1, 2020 (Volume 106, Issue 5) reviews the optimum dose constraints for the rectum in prostate cancer patients being treated with hypofractionation. 
Category
  • Genitourinary Cancer
Format
  • Journal SA-CME
Credits
  • Certificate of Attendance
  • SA-CME

Pages